英國BBI Solutions成立于1986年,是體(ti)外診(zhen)(zhen)斷(duan)(duan)試劑領域專(zhuan)業(ye)(ye)(ye)制(zhi)造(zao)商,為生命科學行業(ye)(ye)(ye)和(he)體(ti)外診(zhen)(zhen)斷(duan)(duan)行業(ye)(ye)(ye)提(ti)供診(zhen)(zhen)斷(duan)(duan)試劑原(yuan)料、標準品及技術服務(wu),現已從一家小型專(zhuan)業(ye)(ye)(ye)公(gong)司成長為業(ye)(ye)(ye)務(wu)生產基地橫跨三(san)個國家的大型企業(ye)(ye)(ye)。
BBI Solutions主要經營產品包括人源抗原、抗體、血清、血漿、臨床化學酶和黃金納米顆粒。
BBI Solutions人源(yuan)蛋白(bai)
BBI Solutions人源蛋白(bai)是從人類(lei)血清(qing)或組(zu)織中純化所得(de),符合倫理法規要求(qiu);重組(zu)蛋白(bai)使用(yong)大腸桿菌和畢(bi)赤酵(jiao)母表達(da)系統,在專(zhuan)業(ye)的(de)實驗室中進行生(sheng)產(chan);去(qu)血清(qing)產(chan)品,可(ke)顯著消除基質效應,提高生(sheng)物標志物的(de)檢測效果(guo),并產(chan)生(sheng)可(ke)重復(fu)的(de)標準曲線。
CA15-3 Cancer Antigen 癌(ai)抗原CA15-3 貨號:P301-4
CA15-3 is a normal product of breast cells, however in cancer it is frequently over-expressed. The CA15-3 marker is most widely used for monitoring the response to therapy of breast cancer patients. It is elevated in up to 70% of patients with metastatic disease, however, as it is only elevated in 3% of those with localised cancer there is no role for screening with this marker.
產品詳情://www.bbisolutions.com/cn/product/ca15-3
希凱生物是英國BBI Solutions授權代理商,更多(duo)產品信(xin)息,歡迎直接與我們聯系~